The current evidence regarding the indication, advantages and risks of red blood cell
transfusion (RBCT) for preterm infants is discussed. This is an important area in …

Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …

Objective Few large cohort studies have reported data on maternal, fetal, perinatal and
neonatal outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS …

OBJECTIVE. To investigate whether it was possible to promote placental blood transfer to
infants at preterm delivery by (1) delaying cord clamping,(2) holding the infant below the …

Background Many patients with COVID-19 have been treated with plasma containing anti-
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …

Background Casirivimab and imdevimab are non-competing monoclonal antibodies that
bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike …

Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of
its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin …

Almost 90% of extremely low birthweight infants receive red blood cell (RBC) transfusion
during their stay in the neonatal unit (NNU). Currently most NNU s use a combination of …

Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …

Objective To assess perinatal outcomes for pregnancies affected by suspected or confirmed
SARS-CoV-2 infection. Methods Prospective, web-based registry. Pregnant women were …